RNA virus population diversity, an optimum for maximal fitness and virulence by Korboukh, V.K. et al.
RNA Virus Population Diversity, an Optimum for Maximal
Fitness and Virulence*
Received for publication, June 26, 2014, and in revised form, September 8, 2014 Published, JBC Papers in Press, September 11, 2014, DOI 10.1074/jbc.M114.592303
Victoria K. Korboukh‡1, Cheri A. Lee‡, Ashley Acevedo§, Marco Vignuzzi§2, Yinghong Xiao§, Jamie J. Arnold‡,
Stephen Hemperly‡, Jason D. Graci‡3, Avery August¶4, Raul Andino§, and Craig E. Cameron‡5
From the Departments of ‡Biochemistry and Molecular Biology and ¶Veterinary and Biomedical Sciences, Pennsylvania State
University, University Park, Pennsylvania 16802 and the §Department of Microbiology and Immunology, University of California at
San Francisco, San Francisco, California 94158
Background: Viral RNA polymerase nucleotide incorporation fidelity contributes to pathogenesis.
Results: A poliovirus mutator strain and its polymerase have been characterized.
Conclusion: Pathogenesis requires optimal polymerase fidelity; not all mutations in a viral genome are linked to polymerase
fidelity.
Significance: Mutator and antimutator phenotypes can be harnessed for the development of viral prophylaxis and antiviral
therapies.
The ability of an RNA virus to exist as a population of geneti-
cally distinct variants permits the virus to overcome events dur-
ing infections that would otherwise limit virus multiplication or
drive the population to extinction. Viral genetic diversity is cre-
ated by the ribonucleotide misincorporation frequency of the
viral RNA-dependent RNA polymerase (RdRp). We have iden-
tified a poliovirus (PV) RdRp derivative (H273R) possessing a
mutator phenotype. GMP misincorporation efficiency for
H273R RdRp in vitro was increased by 2–3-fold that manifested
in a 2–3-fold increase in the diversity of the H273R PV popula-
tion in cells. Circular sequencing analysis indicated that some
mutations were RdRp-independent. Consistent with the popu-
lation genetics theory, H273R PV was driven to extinction more
easily than WT in cell culture. Furthermore, we observed a sub-
stantial reduction in H273R PV virulence, measured as the abil-
ity to cause paralysis in the cPVR mouse model. Reduced viru-
lence correlated with the inability of H273R PV to sustain
replication in tissues/organs in which WT persists. Despite the
attenuated phenotype, H273R PV was capable of replicating in
mice to levels sufficient to induce a protective immune response,
even when the infecting dose used was insufficient to elicit any
visual signs of infection. We conclude that optimal RdRp fidelity is
a virulence determinant that can be targeted for viral attenuation
or antiviral therapies, and we suggest that the RdRp may not be the
only source of mutations in a RNA virus genome.
Major challenges to virus survival occur during interactions
with the host. Viruses struggle with host defense mechanisms,
diverse cellular environments in different tissues, anatomic
restrictions such as the blood-brain barrier, and host-to-host
transmission. The outcomes of these multiple selective pres-
sures determine tissue tropism and, ultimately, the pathogenic
result of an infection. In this dynamic and changing environ-
ment, genetic diversity in RNA virus populations appears to be
critical for fitness and survival and likely contributes to patho-
genesis. For example, a poliovirus (PV)6 mutant expressing a
high fidelity (antimutator) RNA-dependent RNA polymerase
(RdRp) with a change of Gly-64 to Ser (G64S) displays an atten-
uated phenotype in susceptible mice. G64S efficiently replicates
in a number of tissues but is restricted in its ability to access the
central nervous system. Treatment of viral stocks with chemical
mutagens to increase the number of mutations in the G64S
genome to wild-type levels leads to a significant increase in
neuropathogenesis. These observations provide compelling
evidence that reduced population diversity restricts tissue tro-
pism and determines an attenuated phenotype (1– 4).
Both the number of genetic variants in a population and the
speed with which they are created likely determine the effi-
ciency with which a virus can navigate the dynamic environ-
ment in the infected host. Mathematical models on population
genetics, however, identified a theoretical limit to the number
of mutations (extent of genetic diversity) a haploid genome can
withstand when the yield of offspring (fecundity) is fixed (5). It
is therefore assumed that RNA viruses exhibit the highest
mutation frequency tolerable, but the experimental evidence is
limited to circumstances in which viruses are exposed to chem-
ical mutagenesis (6 – 8).
Indeed, existence of an RNA virus on the brink of extinction
has been the explanation for the sensitivity of viruses to nucle-
oside analogues with ambiguous base-pairing capacity (6, 8, 9).
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This class of nucleoside analogues has been termed lethal muta-
gens (6, 8, 9). The most extensively characterized lethal muta-
gen is ribavirin, a drug currently included in the standard of
care for the treatment of hepatitis C virus infection (6, 8 –10). A
complication with the interpretation of these experiments
arises from the fact that lethal mutagens can have pleiotropic
effects on cells, not the least of which is utilization of the com-
pounds by cellular polymerases.
One approach to explore the limits on viral population diver-
sity with the least collateral damage is creation and character-
ization of a virus variant with a mutator phenotype. Poliovirus is
an ideal model system to address this question because of the
myriad tools available to study this virus (11, 12). However, the
only PV RdRp derivative known to exhibit a mutator phenotype
yielded a dead virus, for reasons that may be unrelated to
extinction catastrophe (13). Viable mutator strains have been
identified for coxsackievirus B3 (14) and murine and severe
acute respiratory syndrome coronaviruses (15, 16). For cox-
sackievirus B3, mutations were in the active site of the RdRp.
However, for coronaviruses, mutations were in a putative
proofreading exonuclease (16). Because antimutator strains
were not available for these systems, the question of an optimal
fidelity could not be addressed directly but was inferred (15, 16).
Here, we describe a PV variant with an RdRp derivative
exhibiting a mutator phenotype (H273R). GMP misincorpora-
tion and ribavirin triphosphate utilization efficiencies by
H273R RdRp were significantly increased in vitro, leading to
increased population diversity and ribavirin sensitivity of the
virus in cells. H273R was driven to extinction more easily than
WT in cell culture, indicating that WT virus is on the verge of
the maximal mutation rate that can be tolerated without a loss
in fitness. Interestingly, we observed a substantial reduction in
H273R virulence, measured as the ability to cause paralysis in a
susceptible mouse model (17). Reduced virulence was attribut-
able to the inability of H273R to sustain replication in tissues/
organs that are normally infected by PV. Despite the attenuated
phenotype, H273R was capable of replicating in mice to levels
sufficient to induce a protective immune response at doses in
which inactivated virus would fail to elicit a protective
response. These data demonstrate that population diversity is
optimized for viral fitness. In combination with data for the
high fidelity G64S variant, we conclude that the ability of RNA
viruses to manipulate their genetic diversity confers upon a
population a fast, effective mechanism to adapt to dynamic
environments. However, substantial constraints exist on the
sequence space that can be sampled without consequences for
viral virulence.
MATERIALS AND METHODS
Ethics Statement—This study was carried out in strict
accordance with the recommendations in the Guide for the
Care and Use of Laboratory Animals of the National Institutes
of Health. The protocol was approved by the Institutional Ani-
mal Care and Use Committee at the University of California,
San Francisco, and the Pennsylvania State University (assur-
ance number A3400-01 UCSF and A3141-01 PSU). All efforts
were made to minimize animal suffering.
Cells and Viruses—HeLa S3 cells were obtained from the
American Type Culture Collection (ATCC) and grown in
DMEM/F-12 plus 10% fetal bovine serum, 100 units/ml peni-
cillin, and 100 units/ml streptomycin. PV type 1 Mahoney was
used throughout this study.
Construction of H273R RdRp (3Dpol) Expression Plasmid—
The H273R mutation was introduced into a modified 3Dpol-
coding sequence by using overlap-extension PCR. In brief, the
H273R clone was produced by overlap-extension PCR with oli-
gonucleotides 3D-PV-AvrII-rev (5-CCT GAG TGT TCC
TAG GAT CTT TAG T-3), 3D-PV-H273R-for (5-CTA AAC
CAC TCA CAC AGG CTG TAC AAG AAT AAA ACA-3),
and 3D-PV-PstI-for (5-CCT GAG TGT TCC TAG GAT CTT
TAG T-3), 3D-PV-H273R-rev (5-TGT TTT ATT CTT GTA
CAG CCT GTG TGA GTG GTT TAG-3) and with pET26Ub-
3D-BPKN-I92T (18) as a template. The final product of the
second PCR was purified and digested with PstI and NheI
and ligated into pET26Ub-3D-BPKN-I92T that had been
digested with the same enzymes. The mutation was confirmed
by DNA sequencing (Nucleic Acid Facility, Pennsylvania State
University).
Expression and Purification of PV RdRp Proteins—WT,
G64S, and H273R RdRp derivatives were expressed in Esche-
richia coli by using a ubiquitin fusion system as described pre-
viously (18) and then purified as described previously (1).
Purification, 5-32P Labeling of RNA Oligonucleotides, and
Annealing of RNA Sym/Sub Substrates—RNA oligonucleotides
were purified by denaturing PAGE as described previously (19).
Concentrations were determined by measuring the absorbance
at 260 nm using a Nanodrop spectrophotometer and using the
appropriate calculated extinction coefficient. RNA oligonu-
cleotides were end-labeled by using [-32P]ATP and T4 poly-
nucleotide kinase. Reactions, typically 100 l, contained 1 M
[-32P]ATP, 100 M RNA oligonucleotide, 1 Kinase Buffer,
and 0.4 units/l T4 polynucleotide kinase. Reactions were incu-
bated at 37 °C for 60 min and then placed at 65 °C for 10 min to
heat-inactivate T4 polynucleotide kinase. RNA sym/sub prim-
er-templates were produced by annealing 10 –20 M RNA oli-
gonucleotides in T10E1 (10 mM Tris, pH 8.0, 1 mM EDTA) in a
Progene Thermocycler (Techne). Annealing reactions were
heated to 90 °C for 1 min and slowly cooled (5 °C/min) to 10 °C.
PV RdRp-catalyzed Nucleotide Incorporation—Nucleotide
incorporation experiments were performed as described previ-
ously (20). Briefly, reactions were performed in 50 mM HEPES,
pH 7.5, 10 mM 2-mercaptoethanol, 60 M ZnCl2, and 5 mM
MgCl2. All reactions were performed at 30 °C. Reactions were
assembled by incubating 1 M PV RdRp with 1 M sym/sub
RNA primer-template (0.5 M duplex) for 3 min, allowing
equilibration to 30 °C, and then rapidly mixing with the appro-
priate NTP substrate. Rapid mixing/quenching experiments
were performed by using a model RQF-3 chemical quench-flow
apparatus (KinTek Corp., Austin, TX). Reactions were
quenched by addition of 0.5 M EDTA to a final concentration of
0.3 M. Products were analyzed by denaturing PAGE. Gels were
visualized by using a PhosphorImager and quantified by using
ImageQuant software (GE Healthcare).
Determination of Kinetic Parameters Kd, app and kpol—Data
were fit by nonlinear regression using the program Kaleida-
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Graph (Synergy Software, Reading, PA). Time courses at fixed
nucleotide concentration were fit to Equation 1,
product  A  ekobs  t  C (Eq. 1)
where A is the maximal concentration of product formed; kobs
is the observed first-order rate constant describing product for-
mation; t is the time, and C is a constant. The apparent disso-
ciation constant (Kd, app) and maximal rate for nucleotide
incorporation (kpol) were determined using Equation 2,
kobs 
kpol  NTP
kd, app  NTP (Eq. 2)
Construction of Mutated Viral cDNA Clones and Replicons—
To introduce the H273R mutation into the 3Dpol-coding
sequence of viral cDNA, pMovRA, PCR was performed with
oligonucleotides PV-3D-AvrII-rev, PV-3D-AflII-for (5-AAC
GAT CCC AGG CTT AAG ACA GAT TTT GAG-3) and the
pET26Ub-3D-BPKN-I92T-Arg-273 plasmid as template. PCR
products were purified and digested with AvrII and AflII. The
digested PCR product was ligated into pUC18-BglII-EcoRI-
3CD vector (21), a subclone of the viral cDNA. From this vector,
the fragment between BglII and EcoRI was cloned into the viral
cDNA plasmid (pMovRA). To introduce mutations into the
subgenomic replicon, pRLucRA, the fragment between the
BglII and AvrII sites from the mutated pUC18-BglII-EcoRI-
3CD subclone vector was ligated into pRLucRA. DNA sequenc-
ing was used to verify the integrity of all clones. The H273K and
H273Q mutations were introduced into the 3Dpol-coding
sequence of viral cDNA, pMovRA, and subgenomic replicon,
pRLucRA, by using overlap-extension PCR. In brief, PCR was
performed with oligonucleotides 3D-PV-BglII-for (5-TAG
AGG ATC CAG ATC TTG GAT GCC A-3), 3D-PV-H273K-
rev (5-TTG TTT ATT CTT GTA CAG TTT GTG TGA GTG
GTT TAG-3), 3D-PV-H273Q-rev (5-TTG TTT ATT CTT
GTA CAG CTG GTG TGA GTG GTT TAG-3), and 3D-PV-
EcoRI-ApaI-poly(A)-rev (5-CGC TCA ATG AAT TCG GGC
CCT TTT TTT TTT TTT TTT TTT TCT CC-3), 3D-PV-
H273K-for (5-CTA AAC CAC TCA CAC AAA CTG TAC
AAG AAT AAA ACA-3), and 3D-PV-H273Q-for (5-CTA
AAC CAC TCA CAC CAG CTG TAC AAG AAT AAA ACA-
3) and with pMo-3D-BPKN-I92T as a template. The final
product of the second PCR was purified and digested with BglII
and ApaI and ligated into pMo-3D-BPKN-I92T and pRLuc-
3D-BPKN-I92T that had been digested with the same enzymes.
The mutation was confirmed by DNA sequencing (Nucleic
Acid Facility, Pennsylvania State University).
RNA Transcription—The pMovRA and pRLucRA plasmids
were linearized with EcoRI and ApaI, respectively, and purified
with Qiaex II suspension (Qiagen) by following the manufac-
turer’s protocol. RNA was then transcribed from the linearized
plasmid DNAs in a 20-l reaction mixture containing 350 mM
HEPES, pH 7.5, 32 mM magnesium acetate, 40 mM dithiothre-
itol (DTT), 2 mM spermidine, 28 mM nucleoside triphosphates,
0.025 g/l linearized DNA, and 0.025 g/l T7 RNA poly-
merase. The reaction mixture was incubated for 3 h at 37 °C,
and magnesium pyrophosphate was removed by centrifugation
for 2 min. The supernatant was transferred to a new tube, and
RQ1 DNase (Promega) was used to remove the template. The
RNA concentration was determined by measuring absorbance
at 260 nm, assuming that an A260 of 1 was equivalent to 40
g/ml, and the RNA quality was verified by 0.8% agarose gel
electrophoresis.
Infectious Center Assays—HeLa cells were transfected by
electroporation with 5 g of viral RNA transcript, and these
cells were serially diluted and plated onto HeLa cell monolay-
ers. Cells were allowed to adhere to the plate for 1 h at 37 °C, and
then the medium/PBS was aspirated. Cells were covered with
1 DMEM/F-12 plus 10% fetal bovine serum, 100 units/ml
penicillin, 100 units/ml streptomycin, and 1% agarose. After
2– 4 days of incubation, the agarose overlay was removed, and
the cells were stained with crystal violet.
Virus Isolation, Titer, and One-step Growth Curves—HeLa
cells were transfected by electroporation with 5 g of viral RNA
transcript, added to HeLa cell monolayers and incubated at
37 °C. Upon cytopathic effect, viruses were harvested by three
repeated freeze-thaw cycles, and cell debris was removed by
centrifugation, and virus titers were performed. The resulting
virus stocks were passaged four times on HeLa cell monolayers
at a low multiplicity of infection (m.o.i. of 0.01). For plaque
assays, virus was serially diluted in PBS and placed on cells in
6-well plates to allow the virus to adsorb to the cells, and PBS
was removed and replaced with media containing 1% agarose.
After 2– 4 days of incubation, the agarose overlay was removed,
and cells were stained with crystal violet. Plaques were counted
to determine virus titer in pfu/ml. To analyze one-step virus
growth, cells were infected with virus at a m.o.i. of 10. Virus was
allowed to adsorb, and cells were washed with PBS and media
added. The cells were incubated at 37 °C for various times post-
infection. Virus was harvested by three repeated freeze-thaw
cycles, and virus titers were performed.
RNA Isolation, cDNA Synthesis, and Sequencing to Confirm
the Presence of the H273R Mutation—Viral RNA was isolated
with QIAamp viral RNA purification kit (Qiagen), as recom-
mended by the manufacturer. The 3Dpol cDNA was prepared
from purified viral RNA by reverse transcription with Moloney
murine leukemia virus-RT (New England Biolabs) with oligo-
nucleotide 3D-BamHI-rev (5-GCG GGA TCC TTA CTA
AAA TGAGTC AAG CCA ACG GCG GTA-3). The resulting
DNA product was then PCR-amplified using SuperTaq DNA
polymerase (Ambion) and oligonucleotides 3D-BamHI-rev and
3D-SacII-for (5-GCG CCG CGG TGG AGG TGA AAT CCA
GTG GAT GAG A-3) as primers. The presence of Arg-273 was
determined by sequencing of the nucleic acid obtained in sec-
ond PCR step with oligonucleotide 3D-PV-PstI-for (5-GGA
GTG ATA ACA GGT TCT GCA GTG GGG TGC GAT-3).
Northern Blot Analysis—Total RNA was isolated using TRI
Reagent, separated on a 1% native agarose gel, and transferred
to a nylon membrane by passive capillary blotting, and then
hybridization was performed using PCR-based probes to the
three-dimensional region of the PV genome essentially as
described previously (22).
Subgenomic Replicon Assays—HeLa cells were transfected by
electroporation with 5 g of replicon RNA transcript, trans-
ferred to pre-warmed media in microcentrifuge tubes, and
incubated at 37 °C. At each time point, cells were pelleted by
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centrifugation; media were removed, and cells were lysed using
cell culture lysis reagent (Promega). Lysates were left on ice
until luciferase and protein concentration assays were per-
formed, at which point the lysates were centrifuged to remove
cellular debris and nuclei. Assays were performed by mixing an
equal volume of clarified lysate with luciferase assay substrate
(Promega), and luciferase quantification was carried out as
described by the supplier with a Junior LB 9509 luminometer
(Berthold). Relative light units were adjusted to total protein
concentration in the samples. Protein concentration was mea-
sured at 595 nm using the Bradford reagent (Bio-Rad). For
experiments performed in the presence of ribavirin, HeLa cells
were pretreated with ribavirin prior to transfection, and then
transfected cells were transferred to media containing the same
concentration of ribavirin.
Genomic Sequencing for Mutational Frequency—Twenty
four viral isolates belonging to each of the WT and H273R pop-
ulations were obtained by plaque isolation. Viral RNA was
extracted and purified. PV cDNAs were generated by RT-PCR
using viral RNA. The RT reaction was performed using the
oligo(dT) primer. Two PCR products were obtained for each
viral isolate, a product spanning the 5-UTR and capsid coding
region (nucleotides 300 –3300) and a product spanning 3CD
and 3-UTR (relative light units 5800 –7441). Primers for the
5-product were 5-CAGAGTGTAGCTTAGGC-3 (forward)
and 5-GGTGGACGCGGGCACC-3 (reverse). Primers for
the 3-product were 5-CAGGGATATCTAAATCTC-3 (for-
ward) and 5-CTCCGAATTAAAGAAAAATTTACCC-3
(reverse). Direct sequencing was performed on PCR products.
Mutational Frequency Determination from Viral Stocks by
Circular Sequencing—HeLa cell monolayers (8  106 cells) in
100 mM plates were infected with 8  104 pfu of either WT or
H273R PV (m.o.i. of 0.01). Upon cytopathic effect, virus was
harvested by three freeze-thaw cycles; cell debris was removed
by centrifugation and Nonidet P-40 (Nonidet P-40) added to
0.5% final concentration. The viral supernatant was mixed at a
1:1 ratio with a solution of 20% PEG-8000 and 1 M NaCl, incu-
bated on ice at 4 °C for 12–24 h, and then centrifuged at 8000 
g for 10 min at 4 °C. The pellet was carefully washed with 50 mM
Tris-HCl, pH 8.0, 10 mM NaCl, and then suspended in 50 mM
Tris-HCl, pH 8.0, 10 mM NaCl (1 ml per 10 ml of viral superna-
tant). Viral RNA was extracted using TRIzol reagent, sus-
pended in RNase-free water, and then used for circular
sequencing as described previously (23, 24).
Guanidine Resistance Assay—HeLa cells were infected with
106 pfu of either WT or H273R PV in the presence of 3 mM
guanidine hydrochloride and then washed and overlaid with
agarose media containing 3 mM guanidine hydrochloride. Cells
were incubated for 3– 4 days at 37 °C before being stained with
crystal violet. Plaques were counted to determine the guanidine
resistant frequency (guar/106 pfu).
Effect of Ribavirin on Virus Titer—HeLa cells were infected
with either WT, G64S, or H273R PV at an m.o.i. of 0.01 or 5 in
the presence of 0 –1000 M ribavirin. Upon cytopathic effect,
virus was harvested by three repeated freeze-thaw cycles, and
virus titers were performed.
Ribavirin Sensitivity Assay—HeLa cell monolayers in 6-well
plates were pretreated for 1 h with various concentrations of
ribavirin and then infected with 50 pfu of WT (ribavirin-sensi-
tive), G64S (ribavirin-resistant), or H273R PV, incubated for 20
min to allow for virus adsorption, and then washed and overlaid
with 0.5% agarose media containing the same concentration of
ribavirin. Plates were incubated for 3– 4 days at 37 °C before
overlays were removed, and monolayers were stained with crys-
tal violet. Plaques were counted and compared with the
untreated (0 mM ribavirin) control dish.
Determination of IC50—To determine the IC50 value, the per-
centage of plaques was plotted as a function of ribavirin con-
centration and fit to a sigmoidal dose-response Equation 3,
Y  A  100  A/1  ribavirin/IC50
H (Eq. 3)
where Y is the % of plaques relative to untreated cells; A is the
minimum % of plaques, and H is the Hill slope.
Virus Competition Experiment—HeLa cells were infected at
an m.o.i. of 10 with a virus mixture composed of WT and
H273R PV at a ratio of 1:9. After adsorption, input virus was
removed, and infection was allowed to proceed to cell lysis.
Virus from the supernatants of infected cells was harvested by
three freeze-thaw cycles and used to re-infect fresh HeLa
cell monolayers (passages 1–3). At each passage, viral RNA
was extracted for quantitation using RT-PCR. RT-PCR
experiments amplified polymerase-coding region, and direct
sequencing of the PCR product was performed to determine
the proportion of progeny virus belonging to the WT or
H273R populations.
Virus Dilution—HeLa cells were infected with either WT,
G64S, or H273R PV at a m.o.i. ranging from 1  108 to 10.
Virus was allowed to adsorb, and cells were washed with PBS
and media were added. The cells were incubated at 37 °C for 6 h
post-infection. Virus was harvested by three repeated freeze-
thaw cycles and virus titers were performed. Extinction titers
were performed by standard plaque assay on the isolated viral
stock. Undiluted viral stocks that gave no plaques were consid-
ered below the limit of detection (1 pfu).
Serial/Blind Passage—HeLa cells were infected with P0 virus
at m.o.i. of 0.1, 0.01, and 0.001, were allowed to proceed for 8 h,
and then viruses were harvested by three repeated freeze-thaw
cycles and titered (P1). HeLa cells were infected with P1 virus at
m.o.i. of 0.1, 0.01, and 0.001 and were allowed to proceed for 8 h,
and the viruses were then harvested by three repeated freeze-
thaw cycles (P2, virus titers were not performed at this point).
The titer of P2 virus stock was assumed to be the same as the P1
virus stock for each virus-m.o.i. pair. This titer was then used to
calculate the amount of virus required to achieve m.o.i. of 0.1,
0.01, or 0.001 for subsequent passage infections. After all eight
passages were completed, viruses were collected after each pas-
sage was titered.
Extinction of Viral Populations at Fixed Number of Viral
Genomes—Viral RNA was purified from virus stocks by using
QIAamp viral RNA purification kit (Qiagen) and used for RT-
qPCR to determine genome copies. HeLa cells were infected
with either WT or H273R PV virus that corresponds to a total of
3.18  101, 3.18  102, 3.18  103, 3.18  104, and 3.18  105
viral RNA genomes, and replication was allowed to proceed for
8 h. After 8 h, total RNA from infected cells and supernatant
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was purified by RNeasy Plus mini kit (Qiagen), and viruses were
harvested by three repeated freeze-thaw cycles. For real time
qPCR analysis performed by the Genomics Core Facility of the
Pennsylvania State University, DNase-treated RNA was reverse-
transcribed using the High Capacity cDNA reverse transcription
kit (Applied Biosystems, Foster City, CA) and the protocol pro-
vided with the kit. Quantification by real time qPCR was done by
adding 10 or 20 ng of cDNA in a reaction with 2 TaqMan Uni-
versal PCR Master Mix (Applied Biosystems, Foster City CA) in a
volume of 20 l, with primers 5-ACCCCTGGTAGCAAT-
CAATATCTTAC-3 (forward) and 5-TTCTTTACTTCACC-
GGGTATGTCA-3 (reverse) and probe 5-[6-Fam]-TGTGC-
GCTGCCTGAATTTGATGTGA-3 in a 7300 real time qPCR
system (Foster City CA) machine. A standard curve was generated
using in vitro transcribed RNA.
Mouse Infection, Protection, and Tissue Tropism—Mice were
bred and housed in standard ventilated caging for all experi-
ments. Protocols for animal studies were approved by Pennsyl-
vania State University and University of California at San Fran-
cisco Institutional Animal Care and Use Committee (IACUC).
All experiments were performed in accordance to guidelines
and regulations overseen by the IACUC. Virus stocks were gen-
erated in serum-free media, harvested, and titered. Four- to
6-week-old outbred (ICR) mice transgenic for the PV receptor
(cPVR) were infected with PV at the indicated titer (pfu) by
either intraperitoneal (i.p.) injection in 3 ml of serum-free
media (or mock-infected with 3 ml of serum-free media alone)
or by intramuscular (i.m.) or intracranial injection. Mice were
observed for 14 days for signs of disease and were euthanized
upon showing dual limb paralysis or paralysis such that their
ability to obtain food and water was compromised; this was in
accordance with approval by the IACUC at Pennsylvania State
University. PD50 values were determined by the Reed and
Muench method. Surviving mice were challenged 1 month after
initial infection using the same methods with 5PD50 of WT PV
(1  108 pfu) by i.p. injection and observed for 14 days as above.
For tissue tropism studies, whole organs (brain or spleen) were
harvested from five mice that had been infected intravenously
with 108 or 109 pfu of WT or H273R PV. Each day following
infection, five mice from each group were sacrificed, and tissues
were removed, washed, weighed, and homogenized in 2 ml of
PBS with an Ultraturrax T8 homogenizer (IKA Works Inc.,
Wilmington, NC). Homogenates were clarified of cell debris
and stored at 80 °C. Tissue homogenates were then titered for
virus on HeLa cells by standard plaque assay.
Antibody Neutralization Assay—Serum from immunized
mice was collected and pooled according to immunized dose at
day 25 post-inoculation. Serum was diluted, mixed with 50 pfu
WT PV, incubated at 37 °C for 2 h, and then added to HeLa cell
monolayers. Cells were incubated for 2 days at 37 °C before
being stained with crystal violet.
Virus Purification and Transmission Electron Microscopy—
To obtain highly purified and concentrated viral stocks, three
10-mm plates of HeLa cells were infected with WT or H273R
PV at an m.o.i. of 1. Upon cell death, media and cells were
collected and subjected to three freeze-thaw cycles. Cellular
debris was removed by centrifugation in Beckman JLA-16.250
rotor at 6000 rpm for 15 min at room temperature. The pH of
the supernatant was adjusted to 7– 8, and the virus was precip-
itated with 8% (w/v) polyethylene glycol (PEG 8000) (American
Bioanalytical) and 0.3 M NaCl for 16 h at 4 °C while constantly
rotating. Precipitated virus was centrifuged at 6000 rpm for 30
min at room temperature. The pellet was resuspended in 0.5 ml
of TN buffer (50 mM Tris, pH 8.0, 10 mM NaCl). Two hundred
fifty microliters of this suspension were then overlaid onto a
1.5-ml 30% sucrose cushion (30% sucrose, 30 mM Tris, pH 8.0,
0.1 mM NaCl) and centrifuged in a Sorvall S55S-582 swinging
bucket rotor at 190,000  g for 14 h at 4 °C. The pellet was
resuspended in 100 l of TN buffer with 2% deoxycholic acid.
Virus solution was dialyzed overnight using a 50 –100-kDa cut-
off membrane against 1 liter of TN buffer at 4 °C. After dialysis,
virus solution was subjected to the second purification step
through a 30% sucrose cushion. The final pellet was resuspended
in 100 l of TN buffer and used to prepare samples for transmis-
sion electron microscopy (TEM). Titer of the purified virus was
determined essentially as described above for one-step growth
curve assay. The purified virus was negatively stained on either
200- or 400-mesh Formvar carbon-coated copper grids with 2%
uranium acetate aqueous solution following standard protocols by
the Electron Microscopy facility at Pennsylvania State University.
Transmission electron microscopy images were collected at the
Electron Microscopy facility on a JEM 1200 EXII microscope. To
determine the fraction of empty viral particles, at least 10 images
for each virus were analyzed.
Statistical Analysis—Statistical analyses were performed
using GraphPad Prism 4.0 (La Jolla, CA). The S.E. and S.D.
values are indicated where appropriate. Survival curves were
performed using the product limit method of Kaplan and Meier
and survival curve comparisons using the log rank test as pro-
vided by GraphPad Prism 4. p values are indicated.
RESULTS
H273R Substitution in PV RdRp Produces a Mutator Pheno-
type in Vitro—We previously reported a PV RdRp derivative
(N297E) that exhibits a mutator phenotype (13). In performing
that study, we identified an adventitious mutation in our N297E
RdRp clone that changed His-273 to Arg. Like the high fidelity
G64S RdRp derivative of PV (1– 4), amino acid 273 is located in
the fingers subdomain of the enzyme, remote from the active
site (Fig. 1A). To address the impact of the H273R mutation on
PV RdRp activity, we engineered the H273R mutation into the
WT PV RdRp expression construct (18). We then evaluated
H273R RdRp fidelity in biochemical assays using our self-com-
plementary RNA-primed RNA template (Fig. 1B) (10, 19, 20), in
which the first templating nucleotide is uridine (underlined in
Fig. 1B). The H273R RdRp derivative was compared with WT
and G64S RdRp derivatives. Under conditions in which all three
enzymes exhibited the same efficiency of correct nucleotide
incorporation (n 	 1 product in lanes marked ATP in Fig. 1C),
H273R RdRp was more efficient at GMP misincorporation and
ribavirin incorporation than both WT and G64S RdRps (Fig.
1C). The reduced fidelity of nucleotide addition by H273R
RdRp was further supported by the appearance of products
greater than n 	 1 when ATP and RTP were used as substrates
(lanes 5 and 7 in Fig. 1C). These products of misincorporation
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were not as abundant for WT and G64S RdRps (Fig. 1C). These
data suggest that H273R RdRp is a mutator polymerase.
To establish the magnitude of the fidelity difference between
H273R and WT and to understand the kinetic basis for this
difference, we performed a quantitative pre-steady-state
kinetic characterization of H273R RdRp (Fig. 1D). These results
were compared with those obtained previously for WT and
G64S RdRps (1, 10, 20). The GMP misincorporation efficiency
and ribavirin monophosphate incorporation efficiency of
H273R RdRp were elevated by 2- and 5-fold, respectively, rela-
tive to WT (Fig. 1D). In both cases, the misincorporation was
caused by an increase in the apparent affinity (Kd, app) for the
incorrect nucleotide and an increase in the observed rate con-
stant for nucleotide incorporation (kpol) (Fig. 1D). These results
indicate that the recombinant, purified PV RdRp carrying the
H273R substitution has a lower capacity to discriminate
between the correct and the incorrect nucleotide during the
polymerization reaction.
Replication Characteristics of H273R PV in Cell Culture—An
infectious cDNA clone of Mahoney type 1 PV genome was engi-
neered to encode an RdRp harboring the H273R substitution
such that two transversion mutations would be required to
restore the wild-type amino acid. H273R RNA produced by in
vitro transcription of the mutated cDNA was infectious in HeLa
cells, albeit with a 1.4-fold lower specific infectivity than
observed for WT RNA (Fig. 2A). The H273R population pro-
duced an equal number of plaques at three different tempera-
tures (34, 37, and 39 °C), but the plaque size of the mutant was
slightly smaller than observed for WT (Fig. 2B), suggesting that
the fitness of H273R may be somewhat reduced. Four consec-
utive passages of H273R at low multiplicities of infection
showed no evidence of genetic changes in polymerase-coding
sequence, even at the codon for position 273. Analyses of the
growth kinetics of H273R under one-step growth conditions in
HeLa cells revealed no significant differences relative to WT
(Fig. 2C). However, using a more sensitive assay, a luciferase-
expressing subgenomic replicon, we observed a subtle delay in
H273R replication with respect to WT (see 2.5–5 h post-trans-
fection, Fig. 2D), but by 6 h the mutant reached WT levels of
replication. Evaluation of RNA accumulation by Northern blot-
ting did not reveal this difference (Fig. 2E). We conclude that
the growth properties and genetic stability of H273R are similar
to those observed for WT PV, thus permitting us to evaluate the
biological consequences of increasing mutation frequency both
in cell culture and in a small animal model of infection.
H273R PV Expresses a Mutator Phenotype in Cell Culture—
We determined the genetic diversity of H273R populations
after four passages in cell culture by cloning and sequencing
fragments of the genome encompassing capsid and polymerase
coding regions derived from viral RNA isolated from plaques
FIGURE 1. H273R substitution in PV RdRp produces a mutator phenotype in vitro. A, structure of PV RdRp showing the location of His-273 and Gly-64 (CPK,
red and green, respectively). Palm, fingers, and thumb subdomains are indicated. Conserved structural motifs are colored as follows: A, red; B, green; C, yellow;
D, blue; E, purple; F, orange; G, black. B, primed template used is referred to as sym/sub-U and contains uridine as the first templating base (underlined). C,
reaction products from PV RdRp-catalyzed nucleotide incorporation using the indicated nucleotide and sym/sub-U. H273R RdRp incorporated GMP and
ribavirin monophosphate more efficiently than both WT and the high fidelity variant G64S RdRp. Note the additional misincorporated nucleotides (
n 	 1)
that are observed with H273R RdRp. D, H273R RdRp is less faithful than WT. Kinetic parameters for correct and incorrect nucleotide incorporation catalyzed by
WT, H273R, and G64S RdRp are shown. The relative fidelity or error frequency is shown, (kpol/Kd, app)corr/(kpol/Kd, app)incorr. Values are rounded to one significant
figure. a, values for WT and G64S RdRp were taken from previous studies (1, 20).
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FIGURE 2. H273R PV is viable and replicates stably in cell culture. A, infectious center assay. HeLa cells were transfected by electroporation with 5 g of viral
RNA, and cells were serially diluted and plated onto HeLa cell monolayers. Cells were washed and overlaid with agarose media, and after 2– 4 days of incubation,
the agarose overlay was removed, and the cells were stained with crystal violet. Data are means from three independent experiments. Errors represent  S.E.
B, evaluation of the plaque phenotype and temperature sensitivity of H273R PV. HeLa cells were infected with 50 pfu of either WT or H273R PV, washed, and
overlaid with agarose media. Cells were incubated for 3– 4 days at the indicated temperature before being stained with crystal violet. C, kinetics of virus growth
for H273R PV. Viral titer (pfu/ml) was plotted as a function of time post-infection. Data are means from three independent experiments. Error bars represent 
S.E. D, kinetics of RNA synthesis using a luciferase-expressing, subgenomic replicon. Luciferase specific activity is reported in relative light units (RLU) per g of
total protein in the extract. GAA represents a control for translation of input RNA without replication. The signature GDD motif of the RdRp was changed to GAA.
Data are means from four independent experiments. Error bars represent  S.E. E, Northern blot analysis. HeLa cells were infected with either WT or H273R PV,
and at different times post-infection the total RNA was isolated, and Northern blots were performed. Genomic single-stranded (ss) RNA and replicative form
(RF) are indicated.
FIGURE 3. H273R PV expresses a mutator phenotype in cell culture. A, sequencing analysis and guanidine resistance frequency confirms the increased
mutation rate for H273R PV in tissue culture. Shown are the total number of mutations observed over the total number of nucleotides sequenced and the
calculated average number of mutations per genome. A significant difference in the number of mutations was observed between WT and H273R PV (p  0.002,
Mann-Whitney U test). a, values reported for WT and G64S PV virus are taken from Ref. 4. The calculated guanidine resistance frequency for WT and H273R PV
after infection of HeLa cells with 106 pfu in the presence of 3 mM guanidine hydrochloride is shown. Data are means from four independent experiments. B,
ribavirin sensitivity. 50 pfu of WT, G64S, or H273R PV were used to infect HeLa cell monolayers pretreated with the various concentrations of ribavirin. Plaque
numbers were plotted against ribavirin concentration normalized to untreated (0 mM) control. The solid line represents the fit of the data to a sigmoidal dose
response equation (four-parameter logistic model), yielding IC50 values of 0.55  0.03, 2.05  0.10, and 0.062  0.003 mM for WT, G64S, and H273R PV,
respectively. Data are means from three independent experiments. Error bars represent  S.E. C and D, susceptibility of H273R PV to ribavirin is reduced at high
m.o.i. Shown is the percentage of surviving virus for WT, G64S, and H273R PV after infecting HeLa cells at either low (m.o.i. of 0.01, C) or high (m.o.i. of 5, D) m.o.i.
in the presence of increasing concentrations of ribavirin. Titers were normalized to untreated (0 M) control. The titer (pfu/ml) after infection at low m.o.i. for
WT, G64S, and H273R PV in the absence of ribavirin was 3.5  108, 1.8  108, and 1.6  108, respectively. The titer (pfu/ml) after infection at high m.o.i. for WT,
G64S, and H273R PV in the absence of ribavirin was 1.9  107, 4.7  107, and 1.8  107, respectively. Data are means from three independent experiments. Error
bars represent  S.E. p  0.05 for all samples compared with WT by Student t test. E, percentage of relative light units (RLU) per g at 5 h post-transfection for
WT, G64S, and H273R subgenomic replicon in the absence or presence of ribavirin. Data are means from three independent experiments. Error bars represent 
S.E.
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(Fig. 3A) (1, 4). A 50% increase in mutations was observed in
H273R, averaging 3.0 mutations per genome (Fig. 3A). A phe-
notypic assay for the presence of viral mutants resistant to gua-
nidine (guar), an inhibitor of PV genome replication, was con-
sistent with the sequencing analysis. H273R exhibited a 3-fold
increase in guar frequency relative to WT (Fig. 3A) (1, 4). The
observed mutation frequencies from sequencing reflect aver-
ages at multiple locations within a specific genomic region
(VP1), whereas the phenotypic assay (guar) provides the fre-
quency of a specific transition mutation in the genome. Both
experimental observations support the conclusion that the
arginine substitution at position 273 of the PV RdRp signifi-
cantly increases the virus mutation rate.
Ribavirin is a nucleoside analogue with known antiviral prop-
erties (25). Ribavirin is a mutagen to PV and other RNA viruses
(9, 10). A high fidelity variant of the PV RdRp, G64S, exhibits
reduced sensitivity to ribavirin in cell culture (1– 4). We pre-
dicted that low fidelity variants of the PV RdRp, such as H273R,
would exhibit enhanced sensitivity to ribavirin. Indeed, H273R
demonstrated a substantial increase in sensitivity to the drug
(Fig. 3, B–D). Quantification of this experiment revealed a
9-fold decrease in the concentration of ribavirin required to
reduce the number of plaques by half relative to the untreated
population (IC50, Fig. 3B). The effect of ribavirin was more pro-
nounced at low multiplicities of infection (compare Fig. 3, C
with D) either because certain mutations can be tolerated at a
high m.o.i., because associated virus functions can be comple-
mented, or because at a low m.o.i. the virus undergoes multiple
rounds of replication. These experiments further support the
conclusion that the H273R substitution results in a mutator
phenotype.
The results presented above using luciferase activity pro-
duced from translation and replication of a subgenomic repli-
con suggested that replication of H273R may be slower than
WT (Fig. 2D). However, this observation might result simply
from the reduced specific activity of luciferase caused by the
increased mutational load in the luciferase-coding sequence.
To test this possibility, we used the mutagenic activity of riba-
virin to determine whether or not changes in replication fidelity
alone will produce effects on luciferase-specific infectivity that
are unrelated to RNA copy number. The specific activity of
luciferase varied as a function of polymerase fidelity (Fig. 3E).
We conclude that information on replication kinetics and/or
yield should not be inferred from reporter enzyme activity
when the virus variant exhibits a fidelity phenotype.
A new deep-sequencing approach has been developed that
permits the entire mutational spectrum of an RNA virus to be
elucidated (23, 24). This approach is referred to as circular
sequencing, because fragmented RNA is circularized and the
circularized template was copied reiteratively in a process of
rolling-circle reverse transcription (23, 24). Multiple copies of a
single sequence permits error correction sufficient to call muta-
tions present at a frequency lower than 106 (23, 24). The most
striking finding was that the fold-change in mutation frequency
observed for H273R PV relative to WT PV could be separated
into two categories (Table 1). The first category showed a clear
increase in mutation frequency for H273R PV, consistent with a
mutator polymerase. The second category showed no change at
all in the mutation frequency for H273R PV (Table 1). The
ranked order of mutation types was identical when H273R PV
was compared with WT PV (Table 1). Collectively, these data
suggest two mechanisms (RdRp-dependent versus RdRp-inde-
pendent) driving the genetic diversity of the PV population in
HeLa cells, an unexpected yet exciting finding.
H273R PV Exhibits Reduced Fitness in Cell Culture Relative
to WT PV—Lethal mutagenesis is a prediction of population
genetics theory, which suggests that a 1-log increase in the
progeny per generation (fecundity) would be required to pre-
clude a unit change in the mutation rate from causing extinc-
tion of the viral population (5). Thus, there should be a fitness
penalty associated with the increased mutation frequency
observed for H273R. To examine this prediction, we competed
H273R with WT at an initial WT/H273R ratio of 1:9 (Fig. 4A).
Serial passages revealed a fitness deficit in H273R relative to
WT (Fig. 4A). By the third passage, WT represented the major-
ity of the population and continued to increase in subsequent
passages.
Fitness defects associated with the increased mutation fre-
quency of H273R should also manifest as an increase in the
concentration of virus required for establishment of an infec-
tion because population genetics theory predicts a requirement
for a finite number of viable genomes to avoid extinction (5).
Thus, this minimal concentration should be greater for those
virus populations with a high mutation load (WT and H273R)
than for a high replication fidelity variant (G64S) (5). We eval-
uated the yield of virus produced 6 and 8 h post-infection over
a 9-log range of virus concentrations, expressed as m.o.i. (Fig.
4B). Six-hour time frame was chosen because the virus multi-
plication cycle should be essentially completed for all viruses,
but all progeny should still reside within the infected cells.
Extinction occurred at an m.o.i. (pfu/cell) of 106 for H273R, at
107 for WT, and at 108 for G64S PV (Fig. 4B). This result
provides additional experimental evidence supporting RNA
virus population dynamics predicted by population genetics
theory.
Given that RNA viruses are thought to exist close to their
tolerable mutation load, we anticipated that H273R would be
susceptible to lethal mutagenesis. To test this hypothesis, we
compared the fecundity of H273R with that of WT and G64S at
a low m.o.i. over eight generations. The fecundity of WT
increased during passage, whereas that of G64S PV was
TABLE 1
Mutational spectrum determined by using CirSeq
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unchanged and that of H273R was substantially decreased (Fig.
4C). The fact that the only difference between these PV variants
was their RdRp replication fidelity reveals a striking link
between RdRp error rate, fitness, and evolution of RNA virus
populations. Interestingly, the loss of fitness of H273R was not
observed at higher multiplicities of infection (Fig. 4D, WT con-
trol is shown in Fig. 4E). This observation is consistent with the
theory that extinction of virus populations through lethal
mutagenesis should depend on burst size (5). These results
establish a clear relationship between viral population diver-
sity and fitness in cell culture. It appears that PV has evolved
to an optimal mutation rate, and this mutation rate can be
modulated by amino acid substitutions within the RdRp. The
fitness defect resulting from a higher load of detrimental
mutations is best revealed at low multiplicities of infection,
where we observed population extinction (Fig. 4B) and max-
imal fecundity (Fig. 4, F and G). Of note, we observed a near
2-fold increase in the number of empty particles produced by
H273R relative to both WT and G64S PVs (Fig. 5), suggesting
that determinants of packaging are sensitive to mutational
load and therefore may be useful to ensure that only the most
fit genomes are disseminated.
FIGURE 4. H273R PV exhibits reduced fitness in cell culture relative to WT PV. A, WT out-competes H273R PV. Shown is the percentage of WT and H273R PV
remaining after 1– 4 serial passages. The initial virus mixture contained a ratio of WT/H273R, 1:9. B, dilution drives H273R PV to extinction before WT and G64S.
Shown is the surviving progeny virus (pfu) for WT, G64S, and H273R PV at 6 h post-infection using the indicated inoculum (pfu). Data are means from five
independent experiments. Error bars represent  S.E. The lower limit of detection is one plaque and is indicated by the dashed line. C, polymerase fidelity
controls adaptation. Shown is the surviving progeny virus (pfu) after serial/blind passage of WT, G64S, and H273R PV at an initial m.o.i. of 0.001. D, inoculum size
and mutation frequency affect sustainability of virus population. Shown is the surviving progeny virus (pfu) after serial/blind passage of H273R PV at an initial
m.o.i. of 0.001, 0.01, and 0.1. E, phenotypic changes of cell culture-adapted WT PV population. Shown is the surviving progeny virus (pfu) after serial/blind
passage of WT PV at an initial m.o.i. of 0.001, 0.01, and 0.1. For experiments shown in C–E, HeLa cell monolayers were infected at the indicated m.o.i. of P1 virus,
were allowed to proceed for 8 h, and then viruses were harvested. The titer of virus (pfu/ml) produced during P2 for each virus/m.o.i. pair was assumed to be
constant (i.e. dose-response ratio), and this titer was then used to calculate the amount of the virus required to achieve m.o.i. of 0.1, 0.01, or 0.001 for subsequent
passage infections. After all eight passages were completed, viruses collected after each passage were titered. F, fecundity for WT, H273R, and G64S PV.
Fecundity was calculated as the ratio of progeny (pfu) to inoculum (pfu). Shown is the calculated range for each virus. G–I, progeny of virus relative to the
starting inoculum for each infection from the data shown in B for WT, H273R, and G64S PV. Data are means from five independent experiments. Error bars
represent  S.E.
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All of the experiments presented above were performed
using the pfu as the quantifiable measure of infectious virus.
When we performed blind serial passages of H273R at low mul-
tiplicities of infection, we routinely observed extinction as
shown in Fig. 4, C and D. However, if we quantified the viral
titer, again using pfu, to determine the inoculum, then extinc-
tion was never observed. We eventually reconciled these differ-
ences by realizing that pfu is itself a phenotype, and the number
of genomes per pfu could change from one virus to another. We
used digital PCR to quantify standards used in conventional
RT-qPCR experiments to measure virus titers as genomes or
genomes/ml. For WT PV, 1 pfu equated to 50  10 genomes;
this value increased to 500  100 genomes for H273R PV. The
value for genomes/pfu measured was dependent on several fac-
tors, including m.o.i., m.o.i. used for serial passage, and number
of passages. We were able to use this quantitative approach to
corroborate the observation that H273R is more susceptible to
extinction than WT (Fig. 6).
We conclude that the H273R substitution reduces replica-
tion fidelity of the PV RdRp, which results in a mutator pheno-
type. This mutation appears to drive the virus population over
the maximal tolerated mutation frequency, which over time
leads to extinction of finite virus populations. We thus propose
that H273R should be incapable of sustaining an infection in
vivo due to the inability to overcome the effect of bottlenecking
on population size during infection.
H273R Is Attenuated in Vivo—Thus far, the data suggest that
fitness defects associated with the low replication fidelity of
H273R should manifest under conditions in which the size of
the viral population is forced below the limit required for sus-
tainability. Given the diverse and dynamic nature of the envi-
ronment within an infected host, we predicted that H273R
FIGURE 5. H273R PV identifies RNA packaging as a checkpoint for func-
tional genomes. TEM analysis of the purified viruses. Representative TEM
images at magnification of 30 are shown. White bar in each image repre-
sents 500 nm. White arrows point to virus particles containing RNA, and black
arrows point to empty viral particles. TEM images are shown of WT (A), H273R
(B), and G64S PV (C). Empty particles constitute 35  5, 55  5, and 33  5% of
total viral particles for WT, H273R, and G64S PV, respectively.
FIGURE 6. Extinction of viral populations at fixed number of viral
genomes. Outcome of infection of WT and H273R PV at fixed number of viral
genomes. Total genome copies (output) for WT (A) and H273R (B) at 8 h post-
infection using the indicated inoculum that corresponds to 3.18  101, 3.18 
102, 3.18  103, 3.18  104, and 3.18  105 viral genomes (input). Data are
shown from six independent experiments for each virus. H273R proceeds to
extinction prior to WT after infection at a lower number of viral genomes.
HeLa cells were infected with an equivalent number of genomes for WT and
H273R; replication was allowed to proceed for 8 h and then total RNA and
viruses were harvested. RT-qPCR was performed using purified RNA to deter-
mine genome copies.
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would be attenuated in vivo, where the virus is challenged by
host defense mechanisms, diverse cellular environments in dif-
ferent tissues, and anatomical restrictions, which impose bot-
tlenecks and restrain virus population size. Indeed, H273R virus
presented a highly attenuated phenotype in mice where onset of
paralysis was delayed and observed only at very high viral doses
(Fig. 7, A–F). The 50% paralysis dose (PD50) for H273R was
more than 200-fold higher than for WT (Fig. 7, A–F). Further-
more, intraperitoneal inoculation revealed that the low fidelity
H273R virus exhibited restricted tissue tropism. Although both
WT and H273R viruses were readily isolated over several days
from the spleen and muscle, the H273R mutant was unable to
FIGURE 7. H273R PV is attenuated in vivo. A–F, H273R PV is attenuated in the cPVR mouse model. cPVR mice (4 – 6 weeks old) were infected by either
intraperitoneal (A–C) or intramuscular (D–F) injection with serum-free media containing WT (A and D) or H273R PV (B and E) at the indicated titer (pfu) and
observed for 14 days. Mice that developed the following symptoms, two-limb paralysis or paralysis that compromised the ability to get food and water, were
euthanized. The number of mice per group was n  15 (i.p.) and n  5 (i.m.). PD50 values by i.m. injection (C) for WT and H273R PV were 2  10
7 and 1  109 pfu,
respectively. PD50 values by i.m. injection (F) for WT and H273R PV were 2  10
5 and 6  107 pfu, respectively. PD50 values were determined by the Reed and
Muench method. G–I, viral tissue tropism. Shown are the virus titers (pfu/g) at the indicated days post-infection in tissue collected from mice infected
intravenously (G) with 107 pfu of WT or H273R PV or infected intracranially (H and I) with 105 pfu of WT or H273R PV. The statistical significance of differences
in virus load in brain (H) or in spinal cord (I) between WT and H273R after intracranial inoculation was determined by the Mann-Whitney test. Error bars
represent  S.E.
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establish infection and replicate effectively in the spinal cord
and brain (Fig. 7G), despite these being principal sites of WT PV
replication. Interestingly, intracranial inoculation showed that
H273R PV replicated in brain equivalently to WT (Fig. 7H).
However, H273R PV was still unable to make it to the spinal
cord (Fig. 7I). These data are consistent with restrictions in
neurons giving rise to the observed phenotype.
H273R Elicits a Protective Immune Response—We next
determined the vaccine potential of H273R. First, we tested the
ability of low fidelity H273R PV to elicit humoral immunity
following a single intraperitoneal dose. Neutralization assays
using sera collected from immunized animals 4 weeks post-
infection revealed that H273R PV elicited PV-specific neutral-
izing antibodies and exhibited immunogenicity comparable
with both WT PV and the Sabin type 1 vaccine strain (Fig. 8A).
To further evaluate the immune response elicited by H273R,
we challenged the vaccinated mice with a lethal (5PD50) intra-
peritoneal inoculation of WT PV 1 month after immunization.
Protection of mice from lethal infection correlated with neu-
tralizing antibody levels. Thus, mice inoculated with doses of
H273R at or above 107 pfu exhibited complete protection
against lethal challenge by WT PV (Fig. 7B). Therefore, even
though H273R is attenuated in its ability to replicate and cause
disease in mice, this low fidelity variant elicits a strong immune
response that confers protection.
H273R Phenotype Is Unique—Because H273R is the only via-
ble PV mutant with a mutator phenotype, we asked whether
other substitutions at this position would yield viable mutants
with perturbed polymerase fidelity. We constructed H273K
and H273Q PVs. Neither of these viruses were viable (Fig. 9A).
Interestingly, inviability was not attributable to inactive poly-
merase as evaluation of these variants in the context of a sub-
genomic replicon revealed high levels of replication (Fig. 9B).
Additional studies will be required to fully understand this
observation.
DISCUSSION
An understanding of how genetic diversity of an RNA virus
population impacts its interaction with the cell and, ultimately,
the outcome of infection for the host have important implica-
tions for the development of antiviral therapies and vaccine
strategies. Nucleoside analogues with ambiguous base-pairing
capacity exhibit antiviral activity (6, 8 –10). These agents, which
include the clinically used ribavirin, have been termed lethal
mutagens and are thought to act by increasing the genetic var-
iation of the viral population beyond the extinction threshold
(6, 8 –10). Viral populations exhibiting decreased or increased
genetic diversity are attenuated but replicate in the host and
elicit a protective immune response (4, 14, 16, 26). Together,
these observations suggest an optimal genetic diversity for a
viral population to survive.
Mutation selection balance is a fundamental tenet of popu-
lation genetics theory (5). Reflection of this theory on the evo-
lutionary biology of RNA viruses reinforces the requirement for
a minimal fecundity to sustain a viral population at a given
mutation rate (5). These theoretical considerations relate to
survival of viral populations and not the ability to cause disease.
Only if survival of viral populations alone is sufficient for patho-
genesis will these studies contribute to the prediction of viral
virulence. Forcing a virus population to extinction is a laudable
goal, but forcing a virus population to expression of an avirulent
phenotype may be of great practical utility and more achievable.
This study reports the discovery of a viable PV mutant,
H273R, that expresses a mutator phenotype. This low fidelity
variant in combination with the high fidelity PV, G64S (1– 4),
provides a panel of viruses producing populations with genetic
diversity both higher and lower than WT. Both mutants are
attenuated in an animal model (Fig. 7) (3, 4), suggesting the
existence of an optimal genetic diversity for a pathogenic out-
come of infection. Replication clearly occurs in vivo (Figs. 7 and
8) (3, 4). This observation demonstrates that virus fitness in
tissue culture is insufficient to predict disease in a more realis-
FIGURE 8. H273R PV elicits a protective immune response. A, antibody
neutralization assay. Neutralizing antibody titers (reciprocal of the serum
dilution able to reduce the number of plaques to 50% of 50 pfu WT PV) are
shown for individual trials (solid circles) and as trial means (lines). Titers for
PBS-immunized mice were below the detection level of the assay (indicated
by dashed line). B, mouse protection studies. Mice immunized by i.p. injection
with H273R PV or mock immunized with serum-free media alone (naive) were
challenged 4 weeks after immunization with 5PD50 of WT PV (1  10
8 pfu) by
i.p. injection and observed for 14 days. Mice that developed two-limb paral-
ysis or paralysis that compromised the ability to get food and water were
euthanized. The number of mice per group was n  5. Survival curves for mice
immunized with H273R PV at 107 pfu or greater were significantly higher than
those for mice immunized with control serum-free media (p value of 0.014,
Kaplan-Meier test).
FIGURE 9. Mutations at position 273 other than Arg significantly impact
PV replication. A, infectious center assay. HeLa cells were transfected by
electroporation with 5 g of viral RNA; cells were serially diluted and plated
onto HeLa cell monolayers. Cells were washed and overlaid with agarose
media and after 2– 4 days of incubation; the agarose overlay was removed,
and the cells were stained with crystal violet. Data are means from three
independent experiments. Errors represent  S.E. Plaques were not observed
for H273A, H273N, H273G, H273P, and H273F mutants. B, kinetics of RNA
synthesis using a luciferase-expressing subgenomic replicon. Luciferase-spe-
cific activity is reported in relative light units (RLU) per microgram of total
protein in the extract. WT 	 guanidine HCl (Gu-HCl) represents a control for
translation of input RNA without replication. Guanidine HCl is an inhibitor of
PV replication. Data are means from three independent experiments. Error
bars represent  S.E. Replication was not observed for H273A, H273N, H273G,
H273P, and H273F mutants.
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tic, complex host. Attenuation appears to correlate with both a
reduction of viral load and duration of infection in one or more
specific organs/tissues. Viral load and persistence contribute to
virus dissemination and consequential disease. Both viral load
and persistence will be impacted by fecundity of the viral pop-
ulation. The viral population required for maximal fecundity
and evasion of host immune defenses in one host tissue may be
different from what is optimal in a different tissue.
Population genetics predicts a log-linear relationship between
fecundity and mutation rate, thus providing the theoretical
basis for lethal mutagenesis (5). Here, we provide empirical evi-
dence to support the conclusion that population genetics the-
ory applies to a positive-strand RNA virus in cell culture (Fig.
10A). A 2-fold decrease in mutation frequency leads to a 5-fold
increase in fecundity; a 3-fold increase in mutation frequency
leads to a 10-fold decrease in fecundity (Fig. 4). The reduced
fecundity manifests as enhanced sensitivity to extinction when
the population size is reduced (Fig. 4B) or when the time
required for multiplication is fixed (Fig. 4D). Both of these
experimental observations are likely akin to responses of the
H273R population to bottlenecks in the host that contribute to
the attenuated phenotype.
Our studies suggest that PV fecundity may be determined
directly by genome replication efficiency. This suggestion
derives from the observation that there is either an inverse cor-
relation or no correlation at all between the infecting viral dose
and the amount of progeny produced (Fig. 4, G–I). The virus
concentration independence is consistent with a cis-acting
process, of which genome replication is a prime candidate.
Because the 3-fold increase in mutation rate of H273R PV leads
to as much as a 2-log reduction in fecundity relative to WT PV
(compare Fig. 4, G and H), it is likely that genome replication
represents a fitness peak that is sensitive to mutation. However,
the ability of the fecundity to remain essentially constant over a
5-log range of infecting viral dose while undergoing mutagen-
esis is indeed a robust trait, which may explain the inability of a
mutagen alone to eradicate a viral infection (27).
We and others have suggested that the sensitivity of RNA
viruses to lethal mutagens/mutagenesis reflects the existence of
the viral population on the “threshold of extinction.” This posi-
tion is best illustrated by the line dividing extinction and sur-
vival in Fig. 10A. Placing the data on WT, G64S, and H273R PVs
reported here in this context reveals that PV clearly does not
reside on the threshold of extinction. A plot of mutations per
genome versus fecundity defined a line that predicts a maximal
fecundity of 103 and certain extinction at a value of 4.5 muta-
tions per genome (Fig. 10B). This plot also makes it very evident
that the number of solutions that will lead to WT virulence is
likely small (e.g. the region circled in Fig. 10B) relative to the
viable, attenuated possibilities defined by G64S and H273R PVs
(boxed region Fig. 10B). Recent studies of the attenuated K359R
PV mutant, which exhibits a 10-fold reduction in RNA synthe-
sis relative to WT (28), suggest that a third dimension of speed
should be considered when considering viral population
dynamics (Fig. 10C). The magnitude of this axis is not currently
known, hence the question marks in Fig. 10C.
The development of circular sequencing and its application
to PV provided a complete, quantitative description of the
genetic variation within the PV population (Table 1) (23, 24).
Application of this technique to the H273R PV population sug-
gested that not all observed mutation frequencies were depen-
dent on RdRp fidelity (Table 1). Interestingly, the most abun-
dant mutation in the PV population (C-to-U transition) may
not be attributable to the viral polymerase. Conversion of cyti-
dine to uridine occurs via deamination; whether a cellular
deaminase is required remains to be determined. The other
possible RdRp-independent mutations are transversions that
cannot be explained as easily. Mutations like these in a DNA
system would likely be attributed to a “damaged” templating
base, for example an oxidized guanine (29). Oxidative damage
of RNA occurs (30) but has not been studied for PV. It is also
unknown how efficient and faithful the RdRp is during damage
bypass. Perhaps this observation derives from the mutant
FIGURE 10. PV obeys population genetics theory, but optimal fitness and virulence may be inextricably linked. A and B, shown is a plot of fecundity
(log10) versus mutations per genome for WT, G64S, and H273R PV. Fecundity was calculated as progeny (pfu) per inoculum (pfu) for each virus. The average
fecundity was calculated using the inocula from 103 to 101 for each virus. The solid red line depicts the threshold between viral survival and viral extinction
by lethal mutagenesis, which exhibits a log-linear relationship between fecundity and the number of mutations. The limits of mutational load and fecundity
that will support PV viability is shown as a green rectangle. The orange circle (B) represents viruses exhibiting a mutational load and fecundity near that of WT
capable of exhibiting the most virulent phenotype. The solid line represents the fit of the data to a line yielding a y-intercept of 4.5  0.7 and a slope of 1.5 
0.3. C, population speed represents a third dimension of viral population dynamics. In addition to mutation frequency and population size, the enhanced
attenuation of K359R PV relative to G64S PV demands that our consideration of viral population genetics and dynamics be extended to include rate/efficiency
of nucleotide addition as a third dimension.
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showing increased promiscuity only in certain contexts. Addi-
tional studies will be necessary to clarify this observation.
The ability to design ab initio RNA virus mutants with
altered fidelity could represent a substantial advance for vac-
cine development. Our current understanding of the structure,
function, and mechanism of viral polymerases remains insuffi-
cient to guide such an effort. The viable fidelity mutants of PV
both originate from substitutions at sites of the polymerase
remote from the active site (Fig. 1A). It has recently been sug-
gested that PV RdRp fidelity, and likely the fidelity of all RdRps,
is influenced by dynamics of the enzyme (31, 32). Remote-site
residues would therefore be predicted to alter networks con-
trolling dynamics and could be considered to function by an
allosteric mechanism (32, 33). Empirical evidence for this pos-
sibility was obtained for the antimutator G64S RdRp (32, 33).
Whether or not the mutator H273R RdRp uses a similar mech-
anism remains to be determined. Whatever the mechanism,
there is likely some complexity and much to learn because a
G64S,H273R RdRp retains insufficient activity to observe virus
replication in cells.7
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